华兰股份 reported revenue of ¥0.30B for the period ended 2026-06-30, -3.5% year on year. Net income was ¥0.01B, a 2.4% net margin on a 39.0% gross margin. The largest revenue line is 常规胶塞 at 49% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.30B | -3.5% |
| Gross profit | ¥0.12B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | -83.6% |
| Gross margin | 39.0% | Net margin 2.4% |
| Revenue Q/Q | +30.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 常规胶塞 | ¥0.15B | 49.5% |
| 覆膜胶塞 | ¥0.12B | 39.7% |
| 笔式注射器用(卡式瓶)橡胶组件 | ¥0.03B | 8.8% |
| 其他 | ¥0.01B | 2.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.18B | 61.0% |
| R&D | ¥0.02B | 7.7% |
| SG&A | ¥0.09B | 30.0% |
| Tax & other | ¥0.00B | 0.0% |
| Item | Amount |
|---|---|
| Total assets | ¥2.58B |
| Total liabilities | ¥0.39B |
| Shareholders' equity | ¥2.19B |
| Equity / assets | 84.7% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 312% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林 ・ 雅创电子 ・ 风光股份 ・ 明月镜片 ・ 兆讯传媒 ・ 何氏眼科 ・ 鸿铭股份 ・ 骏成科技 ・ 瑜欣电子
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies